The global Ganciclovir market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Ganciclovir volume and value at global level, regional level and company level. From a global perspective, this report represents overall Ganciclovir market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Ganciclovir in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Ganciclovir manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Roche
Bausch & Lomb
Fresenius Kabi
Luitpold
Huatai Pharmaceutical
Wuhan Hualong Bio-pharmaceutical
Luoxin
HUBEI KEYI
Tungshun Group
Tiantianming

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Injection
Oral

Segment by Application
AIDS
Tube transplant
Malignant neoplasms
CMV Infection